This study is currently not recruiting participants.

A Phase 3 Multi-Center Open-Label Study to Assess the DiagNostic

Not Recruiting
99 years or below
All
Phase 3
1 Location

Brief description of study

This is a phase 3, multi-center, open-label, single-arm, non-randomized study to evaluate the diagnostic performance and safety of 18F-DCFPyL (PyL) PET/CT in subjects with suspected recurrence of prostate cancer and negative or equivocal findings per institutional standard of care conventional imaging.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: TBD
  • Age: 99 years or below
  • Gender: All
Updated on 12 Jun 2019. Study ID: 832477

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.